This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

Register by 26 June to save £1000

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
3-5 November 2026
RAIAmsterdam, Netherlands

Karunakar (Karu) Sukuru, R.Ph., Ph.D
Global Vice President, Pharma Product Development and Head, Scientific Advisory at Catalent
Speaker

Profile

Dr. Karunakar (Karu) Sukuru is a global pharmaceutical R&D leader with over 30 years of experience in drug product development and advanced oral delivery technologies. As Global Vice President of Pharma Product Development and Head of Scientific Advisory at Catalent, he leads nearly 1,000 scientists across 14 international sites, driving innovation in oral delivery of small, mid‑ and large‑molecule therapeutics. A recognized expert in controlled‑release softgel and enabling technologies, Dr. Sukuru holds eight issued patents and more than 20 pending across lyophilized biologics, nanoparticle systems, ASDs and capsule‑shell and fill formulation science. He previously held leadership roles at Endo Pharmaceuticals and Banner Pharmacaps. He is a frequent speaker at AAPS, CRS, FDA and IPC forums and has served as an expert committee member at USP setting standards. Dr. Sukuru obtained his Masters and PH.D., from IIT-BHU, India and B.Pharm., Gulburga University, India He is also a Licensed Pharmacist.